These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 32996835)

  • 1. Treatment of feline gastrointestinal intermediate- or large-cell lymphoma with lomustine chemotherapy and 8 Gy abdominal cavity radiation therapy.
    Gieger TL; Seiler GS; Nolan MW
    J Feline Med Surg; 2021 Jun; 23(6):469-476. PubMed ID: 32996835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A retrospective evaluation of lomustine (CeeNU) in 32 treatment naïve cats with intermediate to large cell gastrointestinal lymphoma (2006-2013).
    Rau SE; Burgess KE
    Vet Comp Oncol; 2017 Sep; 15(3):1019-1028. PubMed ID: 27277825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lomustine, methotrexate and cytarabine chemotherapy as a rescue treatment for feline lymphoma.
    Smallwood K; Harper A; Blackwood L
    J Feline Med Surg; 2021 Aug; 23(8):722-729. PubMed ID: 33176543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of lomustine as a rescue agent for cats with resistant lymphoma.
    Dutelle AL; Bulman-Fleming JC; Lewis CA; Rosenberg MP
    J Feline Med Surg; 2012 Oct; 14(10):694-700. PubMed ID: 22577051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LOPH: a novel chemotherapeutic protocol for feline high-grade multicentric or mediastinal lymphoma, developed in an area endemic for feline leukemia virus.
    Horta RS; Souza LM; Sena BV; Almeida IO; Jaretta TA; Pimenta MM; Reche Júnior A
    J Feline Med Surg; 2021 Feb; 23(2):86-97. PubMed ID: 32684120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemotherapy followed by abdominal cavity irradiation for feline lymphoblastic lymphoma.
    Williams LE; Pruitt AF; Thrall DE
    Vet Radiol Ultrasound; 2010; 51(6):681-7. PubMed ID: 21158247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination chemotherapy in feline lymphoma: treatment outcome, tolerability, and duration in 23 cats.
    Simon D; Eberle N; Laacke-Singer L; Nolte I
    J Vet Intern Med; 2008; 22(2):394-400. PubMed ID: 18312554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination chemotherapy with L-asparaginase, lomustine, and prednisone for relapsed or refractory canine lymphoma.
    Saba CF; Thamm DH; Vail DM
    J Vet Intern Med; 2007; 21(1):127-32. PubMed ID: 17338160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lomustine for treatment of mast cell tumors in cats: 38 cases (1999-2005).
    Rassnick KM; Williams LE; Kristal O; Al-Sarraf R; Baez JL; Zwahlen CH; Dank G
    J Am Vet Med Assoc; 2008 Apr; 232(8):1200-5. PubMed ID: 18412534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechlorethamine, vincristine, melphalan and prednisolone rescue chemotherapy protocol for resistant feline lymphoma.
    Martin OA; Price J
    J Feline Med Surg; 2018 Oct; 20(10):934-939. PubMed ID: 29065803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retrospective evaluation of nimustine use in the treatment of feline lymphoma.
    Sakai K; Hatoya S; Furuya M; Nabetani T; Kanegi R; Shimamura S; Tani H; Shimada T
    Vet Med Sci; 2022 Jan; 8(1):3-8. PubMed ID: 34599792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of a multiagent chemotherapy protocol combining vincristine, cyclophosphamide, mitoxantrone and prednisolone (CMOP) for treatment of feline intermediate-large cell lymphoma.
    Webster J; McNaught KA; Morris JS
    J Feline Med Surg; 2024 Apr; 26(4):1098612X241234614. PubMed ID: 38647264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of feline intermediate to high-grade alimentary lymphoma: A retrospective evaluation of 55 cats treated with the VAPC combination chemotherapy protocol (2017-2021).
    Moore AS; Frimberger AE
    Vet Comp Oncol; 2024 Mar; 22(1):106-114. PubMed ID: 38152842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined chemoradiation for the management of nasal natural killer (NK)/T-cell lymphoma: elucidating the significance of systemic chemotherapy.
    Guo Y; Lu JJ; Ma X; Wang B; Hong X; Li X; Li J
    Oral Oncol; 2008 Jan; 44(1):23-30. PubMed ID: 17306611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pegylated asparaginase in feline high-grade lymphoma: clinical results of single injection and continued incorporation into a modified COP regimen.
    Krupa A; de Vos J; Van Eetvelde L; Teske E
    J Feline Med Surg; 2022 Aug; 24(8):e203-e213. PubMed ID: 35748790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A dexamethasone, melphalan, actinomycin-D and cytarabine chemotherapy protocol as a rescue treatment for feline lymphoma.
    Elliott J; Finotello R
    Vet Comp Oncol; 2018 Mar; 16(1):E144-E151. PubMed ID: 29044884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of Lomustine and Prednisolone as First-Line Treatment in Canine Multicentric Lymphoma.
    Catalucci C; Bianchi ML; Treggiari E; Pieri M; Ruess K; Valenti P
    Vet Comp Oncol; 2024 Sep; 22(3):422-428. PubMed ID: 38890811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Feline high-grade and large granular lymphocyte alimentary lymphomas treated with COP- or CHOP-based chemotherapy: A multi-centric retrospective study of 57 cases.
    Bernardo Marques G; Ponce F; Beaudu-Lange C; Béguin J; Boissy L; Chavalle T; Denoeux P; Diop N; Ferro L; Floch F; Lajoinie M; Sayag D; Barrett LE; Chamel G
    Vet Comp Oncol; 2024 Jun; 22(2):186-197. PubMed ID: 38356238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase I evaluation of CCNU (lomustine) in tumor-bearing cats.
    Rassnick KM; Gieger TL; Williams LE; Ruslander DM; Northrup NC; Kristal O; Myers NC; Moore AS
    J Vet Intern Med; 2001; 15(3):196-9. PubMed ID: 11380027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective clinical trial to compare vincristine and vinblastine in a COP-based protocol for lymphoma in cats.
    Krick EL; Cohen RB; Gregor TP; Salah PC; Sorenmo KU
    J Vet Intern Med; 2013; 27(1):134-40. PubMed ID: 23157371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.